Enumeral
id:
enumeral-261-11036655
title:
Enumeral
text:
Enumeral was a Cambridge, Massachusetts-based biotechnology company which developed monoclonal antibody immunotherapies through an 'immunoprofiling' platform that allowed it to scan the human immune microenvironment and identify and validate potential drug candidates. The company filed for Chapter 11 bankruptcy and arranged to sell its assets to Xoma Corporation in January 2018.
brand slug:
wiki
category slug:
encyclopedia
description:
Massachusetts biotechnology company, 2009–2018
original url:
https://en.wikipedia.org/wiki/Enumeral
date created:
date modified:
2023-12-14T19:42:31Z
main entity:
{"identifier":"Q25111091","url":"https://www.wikidata.org/entity/Q25111091"}
image:
fields total:
13
integrity:
14